News

SARS-CoV-2 turned up extensively in the heart of a girl who died of cardiac complications from multisystem inflammatory syndrome in children (MIS-C), according to a case report from Brazil. Viral particles were found in the 11-year-old’s cardiomyocytes, endothelial cells, mesenchymal cells, and inflammatory cells, Marisa Dolhnikoff, MD, of the Universidade de São Paulo, Brazil, and
0 Comments
If you have diarrhea, fever or stomach cramps, and you recently polished off a chicken salad sandwich, the onions you added might be to blame. Red onions distributed by Thomson International Inc.’s facility in Bakersfield, California, were recalled by the Food and Drug Administration on August 1 due to possible salmonella contamination. The FDA also
0 Comments
Welcome to this week’s edition of Healthcare Career Insights. This weekly roundup highlights healthcare career-related articles culled from across the Web to help you learn what’s next. Lisa Grabl is president of the locum tenens division of CompHealth, the nation’s largest locum tenens physician staffing company and a leader in permanent and temporary allied healthcare
0 Comments
In journalism, “Man Bites Dog” is news. Pooches biting fewer people, however, is not. But maybe it should be, considering that dog bites declined a whopping 9% between 2017 and 2018, according to an April 2019 press release from the American Veterinary Medical Association. The AVMA reported that dog bites fell from 18,522 to 17,297
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Immune system memory T-cell levels accurately corresponded with SARS-CoV-2 severity in the first study to evaluate a wide range of responses, from persons who were healthy to those who were severely ill. The researchers also evaluated responses of exposed family members.
0 Comments
First things first. Oleandrin, derived from the toxic plant oleander, might be a life-saver, if that life is being threatened by certain cardiac events. Even then, medical experts say, its toxicity levels are such that one slip-up, like a wrong dose, could prove fatal.  This plant is known as a cardiac glycoside. Second. Many peer-reviewed papers exist in the National Institutes of Health’s database,
0 Comments
Use of tumor necrosis factor (TNF) inhibitors in patients with autoimmune diseases may increase risk for inflammatory central nervous system (CNS) outcomes, new research suggests The nested case-control study included more than 200 participants with diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease. Results showed that exposure to TNF inhibitors was significantly associated with
0 Comments
If you’ve been itching to travel again, you likely also are wondering when will it be safe to fly. A research letter reviewing the effect of COVID-19 infected passengers on a flight in March attempted to answer that question. The case series, published in JAMA on August 18, is based on the experiences of 102 passengers who were on a
0 Comments
OMSK, Russia (Reuters) – Russian doctors said on Friday gravely ill Kremlin critic Alexei Navalny could be flown to Germany to receive medical attention after the politician’s allies accused the Russian authorities of deliberately trying to stop his evacuation. Navalny, a long-time opponent of President Vladimir Putin and his lieutenants and a campaigner against corruption,
0 Comments
On the heels of an onion recall, due to possible salmonella contamination, two more recalls occurred over the past two days – one for shrimp and another for peaches. On August 19, ALDI stores stopped selling and voluntarily recalled Wawona-brand bagged peaches sold in 2-pound clear plastic bags. According to the Food and Drug Administration,
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think you need to know about today:  Immune Responses Explained Although reports of weak or short-lived antibody responses in patients with COVID-19 have raised concerns that vaccines won’t be protective against
0 Comments
Frequently, trainees ask me why they need a dedicated infectious disease guide. Why can’t they just use a drug guide such as Epocrates or Lexicomp or reference apps such as UpToDate, DynaMed, or Essential Evidence Plus? Perhaps they could. Or, trainees would ask, why can’t they just use a paper version like the old Sanford
0 Comments
As we continue to search for effective COVID-19 treatments, use of blood plasma from people who recovered from the virus seemed like a good thing. But on Friday morning, The New York Times reported that the Food and Drug Administration has put a hold on their emergency approval. The article also says that leaders at the
0 Comments
Editor’s Note: This transcript from the August 20 episode of the Blood & Cancer podcast has been edited for clarity. Click this link to listen to the full episode. David Henry, MD: Welcome to this Blood & Cancer podcast. I’m your host, Dr. David Henry. This podcast airs on Thursday morning each week. This interview
0 Comments
Forty-nine states are seeking a total of $2.2 trillion from Purdue Pharma L.P. for their role in the opioid epidemic, according to a Reuters report. Purdue makes OxyContin, an opioid prescription analgesic. It is alleged that Purdue marketed the painkillers to physicians but did not do enough to explain the possibility of addiction and overdose. Earlier
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think you need to know about today: Serological Testing Guidelines Updated The Infectious Diseases Society of America (IDSA) published updated guidelines on antibody testing today, which describe both the best time
0 Comments
During the course of the pandemic, medical centers spun out new treatment protocols on the fly. Now the institutions are racing to develop potential vaccines and therapeutics, and using big data to tailor their treatments to individual patients, physician leaders told The Hill during an online panel discussion Wednesday afternoon, sponsored by the the Association
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. At the end of June, with hundreds of his workers already infected with COVID-19 and several dead, Kenneth Sullivan, the CEO of Smithfield Foods, the world’s largest pork producer, sent a pointed letter to two U.S. senators who had launched an
0 Comments
Back-to-school might have been a stressful season in previous years, but in 2020, back-to-school is a social and political hot button issue. And while the debate about K-12 schools reopenings continues, some colleges are back in session and already scrambling because of new COVID-19 infections. This week has seen significant changes at universities that originally
0 Comments
Opioids don’t belong on the menu for managing acute pain from non–low back musculoskeletal injuries, except in cases of severe injury or when first-line therapies don’t work, according to new guidance from the American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP). “Opioid therapies are associated with little to no benefit
0 Comments
The investigational atypical antipsychotic ALKS 3831 — combination olanzapine/samidorphan for the treatment of schizophrenia and bipolar I disorder — led to significantly less weight gain than olanzapine (Zyprexa) alone, in the 24-week phase III ENLIGHTEN-2 study. The drug is currently under FDA review with a PDUFA target action date of Nov. 15, 2020. (American Journal
0 Comments
CBD has been taking the health and wellness industries by storm. From oils and tinctures to gummies and lotions, the numerous varieties of CBD products available today are remarkable. The incremental growth of the CBD oil market alone is estimated to be $3.52 billion between 2019 and 2024. But what actually is CBD and how
0 Comments